Understanding the impact of immune-mediated selection on lung cancer evolution

被引：6
|
作者：
Rosenthal, Rachel [1 ,2 ]
Swanton, Charles [1 ,2 ,3 ]
McGranahan, Nicholas [2 ,4 ]
机构：
[1] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England
[2] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, London, England
[3] Univ Coll London Hosp, Dept Med Oncol, London, England
[4] UCL, Canc Inst, Canc Genome Evolut Res Grp, London, England
来源：
BRITISH JOURNAL OF CANCER | 2021年 / 124卷 / 10期
基金：
欧盟地平线“2020”; 英国惠康基金; 英国医学研究理事会; 欧洲研究理事会;
关键词：
D O I：
10.1038/s41416-020-01232-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Understanding how a tumour evolves and avoids immune recognition is paramount to improving cancer immunotherapy and patient outcome. Here we examine our recent integration of multi-region genomic, transcriptomic, epigenomic, pathology, and clinical data, highlight the need for a systematic examination of immune escape mechanisms, and discuss implications for immunotherapy approaches.
引用
收藏
页码：1615 / 1617
页数：3
相关论文
共 50 条
  • [1] Understanding the impact of immune-mediated selection on lung cancer evolution
    Rachel Rosenthal
    Charles Swanton
    Nicholas McGranahan
    British Journal of Cancer, 2021, 124 : 1615 - 1617
  • [2] Immune-Mediated Lung Diseases
    Jacobs, Kathleen
    Kligerman, Seth
    SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (03) : 213 - 228
  • [3] Immune-mediated lung injury
    Karampitsakos, Theodoros
    Spagnolo, Paolo
    Tzouvelekis, Argyris
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] Regenerative lineages and immune-mediated pruning in lung cancer metastasis
    Laughney, Ashley M.
    Hu, Jing
    Campbell, Nathaniel R.
    Bakhoum, Samuel F.
    Setty, Manu
    Lavallee, Vincent-Philippe
    Xie, Yubin
    Masilionis, Ignas
    Carr, Ambrose J.
    Kottapalli, Sanjay
    Allaj, Viola
    Mattar, Marissa
    Rekhtman, Natasha
    Xavier, Joao B.
    Mazutisz, Linas
    Poirier, John T.
    Rudin, Charles M.
    Pe'er, Dana
    Massague, Joan
    NATURE MEDICINE, 2020, 26 (02) : 259 - +
  • [5] Prevalence of Immune-mediated Inflammatory Diseases in Patients with Lung Cancer
    Saad, Marina
    Mirizzi, Francesca Mandurino
    Casartelli, Anna
    Spitaleri, Debora Maria
    Casartelli, Anna
    Milani, Lisa
    Croce, Giuseppe
    Lazzaroni, Giada
    Radovanovic, Dejan
    Santus, Pierachille
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [6] Regenerative lineages and immune-mediated pruning in lung cancer metastasis
    Ashley M. Laughney
    Jing Hu
    Nathaniel R. Campbell
    Samuel F. Bakhoum
    Manu Setty
    Vincent-Philippe Lavallée
    Yubin Xie
    Ignas Masilionis
    Ambrose J. Carr
    Sanjay Kottapalli
    Viola Allaj
    Marissa Mattar
    Natasha Rekhtman
    Joao B. Xavier
    Linas Mazutis
    John T. Poirier
    Charles M. Rudin
    Dana Pe’er
    Joan Massagué
    Nature Medicine, 2020, 26 : 259 - 269
  • [7] Cancer as an immune-mediated disease
    Shurin, Michael R.
    IMMUNOTARGETS AND THERAPY, 2012, 1 : 1 - 6
  • [8] Immune-mediated hemolytic anemia: understanding the nemesis
    McCullough, S
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2003, 33 (06) : 1295 - +
  • [9] Immune-mediated thrombocytopenia and hypothyroidism in a lung cancer patient treated with nivolumab
    Jotatsu, Takanobu
    Oda, Keishi
    Yamaguchi, Yudai
    Noguchi, Shingo
    Kawanami, Toshinori
    Kido, Takashi
    Satoh, Minoru
    Yatera, Kazuhiro
    IMMUNOTHERAPY, 2018, 10 (02) : 85 - 91
  • [10] Immune-mediated lung diseases: A narrative review
    Sweis, Jaleel Jerry G.
    Sweis, Nabil W. G.
    Alnaimat, Fatima
    Jansz, Jacqueline
    Liao, Ting-Wei Ernie
    Alsakaty, Alaa
    Azam, Abeera
    Elmergawy, Hesham
    Hanson, Hali A.
    Ascoli, Christian
    Rubinstein, Israel
    Sweiss, Nadera
    FRONTIERS IN MEDICINE, 2023, 10
12345